Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016653-17Phase 4Terminated
Phase 4, randomised, open-label trial in hypotension comparing Immediate dopamine strategy with Selective dobutamine strategy (2 arms). Primary endpoint: Primary composite endpoint. Started Dec 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016653-17.